Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
High drug development costs from increasingly complex products have pushed pharma companies to accelerate timelines as much as possible, creating a “race to market” of sorts. But scaling up too quickly has its risks — risks that the right CDMO partner can help mitigate.
Watch Thermo Fisher Scientific’s on-demand webinar, “Navigating a smarter race to market for oral solid-dose products” to learn: